Supreme Court to Review Abortion Pill Restrictions as Abortion Debate Intensifies

The Supreme Court has now joined the case in court over the abortion pill mifepristone. This is a big change.

Supreme Court to weigh restrictions for abortion pill mifepristone (Photo: USA Today)

Supreme Court Intervention

The Supreme Court has joined the ongoing legal fight over the abortion pill mifepristone, which is a big change. Following the court’s decision to overturn Roe v. Wade, the abortion argument has become more heated again. People who are pregnant, voters, and legal organizations still dealing with the effects of the 1973 Roe v. Wade decision were very upset about the case in question, which was about putting big limits on access to mifepristone.

This abortion-related legal battle has far-reaching implications. According to reports, the court is expected to rule in June, during the 2024 presidential election. The Biden administration and medication manufacturer’s cases will be heard by the court amid widespread implications from last year’s momentous abortion verdict. The recent Texas verdict on a woman’s right to abortion based on legal grounds is one of several state courts examining high-stakes abortion regulations.

Some Democrats want President Joe Biden to make abortion rights a prominent subject of his reelection campaign. In light of this, the White House has reiterated its support for the FDA’s independent approval and regulation of mifepristone as a safe and effective drug. A Louisiana federal appeals court order to restrict mifepristone availability has sparked a legal impasse as both sides prepare to appeal to the Supreme Court.

READ ALSO: Texan Seeking Abortion Approval Heads Out Of State For The Procedure

However, the Supreme Court’s rejection of a separate legal challenge to the FDA’s fundamental jurisdiction to authorize the drug implies that prospective restrictions are the main concern rather than the drug’s approval and regulatory structure.

The Alliance for Hippocratic Medicine, represented by the conservative legal advocacy organization Alliance Defending Freedom, claims that the FDA overstepped its authority in authorizing mail-order mifepristone prescriptions, endangering women’s safety. The dispute also centers on the drug’s safety compared to Tylenol and Viagra, and anti-abortion groups challenge the FDA’s recommendation.

READ ALSO: Texas Woman Challenges Abortion Ban In Landmark Lawsuit Due To Fetal Diagnosis